Search
  • Contact Us
  • Careers
Menu
  • Contact Us
  • Careers
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Applied Therapeutics logo
Applied Therapeutics logo
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Careers
    • Mission
    • Culture
      • Diversity & Inclusion
    • Contact Us
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Understanding Diabetic Cardiomyopathy
    • Understanding Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor FAQs
    • Email Alerts
    • Investor Contacts
Applied Therapeutics logo
Executive Leadership Team
CEO & Founder Shoshana Shendelman

Shoshana Shendelman

CEO & Founder

Chief Medical Officer Riccardo Perfetti

Riccardo Perfetti

Chief Medical Officer

Chief Commercial Officer Adam Hansard

Adam Hansard

Chief Commercial Officer

Leadership

  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board
Menu
  • Executive Leadership
  • Board of Directors
  • Scientific Advisory Board

In the about us section

BehindBottomNav-SmallerSwoosh-min
Swoosh Background-min
Leadership
Mission
Culture
Contact
Applied Therapeutics logo
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
Menu
  • About Us
  • Pipeline
  • Patients & Caregivers
  • Investors & Media
  • Terms of Use
  • Privacy Policy
Linkedin Facebook-square Twitter-square

©2020 Applied Therapeutics All Rights Reserved

Linkedin Facebook-square Twitter-square
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
Menu
  • About Us
    • Leadership
      • Executive Leadership
      • Board of Directors
      • Scientific Advisory Board
    • Mission
    • Culture
    • Contact
  • Pipeline
    • AT-007
    • AT-001
    • AT-003
    • AT-104
    • Clinical Trials
  • Patients & Caregivers
    • Galactosemia
    • SORD Deficiency
    • PMM2-CDG
    • Diabetic Cardiomyopathy
    • T-ALL
    • Advocacy & Engagement
  • Investors & Media
    • Stock Info
    • Financial Info
    • Corporate Governance
    • Events
    • Press Releases
    • Presentations & Publications
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • Investor Contacts
  • Terms of Use
  • Privacy Policy
Applied Therapeutics logo

©2020 Applied Therapeutics All Rights Reserved